BAC
Bank of America Corporation
BAC's outlook is improving, though it still trails on the overall score.
NWBI
Northwest Bancshares, Inc.
NWBI has the edge over BAC overall, supported by stronger valuation and stronger fundamentals.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
NWBI Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
NWBI's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like NWBI.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
NWBI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $14.43 | -4.7% |
| Current | 11x | $15.13 | — |
| Forward | 11x | $15.13 | — |
| Fair | 14x | $18.28 | +21% |
| Expensive | 17x | $22.33 | +48% |
Historical ranges are pointers, not guarantees.
NWBI has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
NWBI Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for NWBI, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over NWBI on earnings, with more consistent year-over-year improvement.
NWBI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.43 | +6.8% |
| Q3 2026 | $1.34 | +52% |
| Q2 2026 | $1.02 | -8.9% |
| Q1 2026 | $0.92 | +2.2% |
| Q4 2025 | $0.92 | +16% |
| Q3 2025 | $0.88 | +16% |
| Q2 2025 | $1.12 | +38% |
| Q1 2025 | $0.90 | -13% |
| Q4 2024 | $0.79 | -25% |
NWBI earned $1.34 per share over the past year, up 52% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
NWBI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $184.9M | +9.9% |
| Q2 2026 | $181.2M | +20% |
| Q1 2026 | $175.1M | +12% |
| Q4 2025 | $179.9M | +17% |
| Q3 2025 | $168.2M | +21% |
| Q2 2025 | $150.4M | +53% |
| Q1 2025 | $156.2M | +19% |
| Q4 2024 | $154.3M | +14% |
NWBI has the edge over BAC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 36% | +34 points |
| Q2 2026 | 39% | +9.5 points |
| Q1 2026 | 38% | +1.9 points |
| Q4 2025 | 33% | +5.1 points |
| Q3 2025 | 2.1% | -29 points |
| Q2 2025 | 29% | +23 points |
| Q1 2025 | 36% | +7.4 points |
| Q4 2024 | 27% | +0.3 points |
NWBI has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
NWBI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $18.9M | -51% |
| Q2 2026 | $26.1M | +$32.1M |
| Q1 2026 | $69.6M | -34% |
| Q3 2025 | $38.3M | -59% |
| Q2 2025 | -$6M | -115% |
| Q1 2025 | $105.8M | +50% |
| Q3 2024 | $93.3M | +$98.3M |
| Q2 2024 | $40.7M | +77% |
NWBI's free cash flow was $118M over the past year, down 49% from the year before. Free cash flow isn't a meaningful measure for financial services companies like NWBI.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over NWBI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
NWBI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +122K shares |
| 1 year | +0.3% | +481K shares |
| 3 years | +15% | +19.5M shares |
| 5 years | +15% | +19.6M shares |
| Available history | +38% | +40.7M shares |
NWBI has 147M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | $18.8M |
| Q2 2021 | $465,000 |
| Q1 2021 | $4.6M |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
NWBI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.8x | Net Cash |
| Q2 2026 | -0.7x | Net Cash |
| Q1 2026 | -1.0x | Net Cash |
| Q4 2025 | -0.7x | Net Cash |
| Q3 2025 | 1.4x | Healthy |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 0.2x | Very low |
NWBI has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
NWBI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.1 | Neutral |
| Stochastic | 43.8 | Neutral |
NWBI's weekly RSI is 54 (neutral) and its Stochastic is 44 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
NWBI PE vs Financial Services Sector
| Metric | NWBI | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 13% below |
| PE % | 31 | 63 | 32 pts below |
NWBI has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
NWBI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $15.2 | 0.1% below |
| 20 week MA | $15.3 | 1.3% below |
| 50 week MA | $14.0 | 8% above |
| 100 week MA | $13.2 | 15% above |
| 200 week MA | $12.6 | 20% above |
NWBI has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
NWBI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.6 | $12.6 | -24% |
| 2021 | $12.6 | $14.0 | +12% |
| 2022 | $14.0 | $14.0 | +0.2% |
| 2023 | $14.0 | $12.5 | -11% |
| 2024 | $12.5 | $13.3 | +6.2% |
| 2025 | $13.3 | $12.3 | -7.5% |
| 2026 YTD | $12.3 | $15.1 | +24% |
NWBI has the edge over BAC on returns for 2026, with the stronger performance.